Avanos Medical (AVNS) EV to FCF (2014 - 2026)

Avanos Medical has disclosed EV to FCF across 13 years of filings, most recently posting 35.44 for Q1 2026.

• In Q1 2026, EV to FCF fell 219.06% year-over-year to 35.44; the TTM figure through Mar 2026 stood at 78.44 (up 1481.07% YoY), while the FY2025 annual figure was 10.02, up 33.13% from the prior year.
• EV to FCF came in at 35.44 for Q1 2026 at Avanos Medical, down from 20.28 in the prior quarter.
• In the past five years, EV to FCF ranged from a high of 139.41 in Q4 2023 to a low of 462.83 in Q1 2022.
• Average EV to FCF over 5 years is 26.56, with a median of 29.77 recorded in 2025.
• The largest YoY upside for EV to FCF was 254.88% in 2023 against a maximum downside of 429.5% in 2023.
• Over 5 years, EV to FCF stood at 39.28 in 2022, then soared by 254.88% to 139.41 in 2023, then plunged by 91.57% to 11.75 in 2024, then surged by 72.54% to 20.28 in 2025, then sank by 274.77% to 35.44 in 2026.
• Per Business Quant data, the three most recent EV to FCF figures were 35.44 in Q1 2026, 20.28 in Q4 2025, and 66.58 in Q3 2025.